Clinical and laboratory studies have suggested that the currently approved vaccine is less effective in the population of COPD patients than in healthier patients, and to date no randomized-controlled trial of pneumococcal vaccination for COPD patients has demonstrated any beneficial effect. The ...
Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. Background. Use of heptavalent protein-polysaccharide pneumococcal conjugate vaccine (PCV7) has been associated with decreases in PCV7-type invasive pneumo... LL...
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) +90472 each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) HCPCS codes co...
- 《Vaccine》 被引量: 66发表: 2007年 Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine (pneumococcal polysaccharide (PPS)-23) with respect to immunogenicity and serum opsonic activity in patients with chronic obstructive pulmonary disease (COPD)... S Jonsson...
Influenza and Pneumococcal Vaccine Coverage Rates among Patients Admitted to a Teaching Hospital in South Korea BACKGROUND: Influenza and pneumococcal vaccinations can reduce morbidity and mortality especially in the elderly and patients with chronic medical disease... TU Yang,JY Song,NJ Yun,... - ...
Influenza vaccine for patients with chronic obstructive pulmonary disease BACKGROUND: Influenza vaccinations are currently recommended in the care of people with COPD, but these recommendations are based largely on evidence from ... PJ Poole,E Chacko,RW Wood-Baker,... - John Wiley & Sons, Ltd ...
A medical professional examines the significant patient burden imposed by pneumococcal infections, highlighting how this burden drove the development of innovative vaccine technologies. Discuss the patient burden of pneumococcal infections that led to the development of novel vaccines....
Publicly funded infant 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in Ontario, Canada in 2005 and was replaced by 10- and 13-valent vacci... GH Lim,AE Wormsbecker,A Mcgeer,... - 《Vaccine》 被引量: 50发表: 2013年 Prospects for pneumococcal vaccination in African children...
Also, significantly more participants with pneumococcal pneumonia died in the placebo group than in the vaccine group: 35.1% vs 0%, respectively. The limitation of this research is that it was conducted on patients in a limited situation, namely elderly care facilities. Recen...
Background Patients with chronic obstructive pulmonary disease (COPD) are at elevated risk of pneumococcal infection. A 13-valent pneumococcal conjugate vaccine (PCV13) was approved for protection against invasive disease and pneumonia c... Jose,Miguel,Rodríguez,... - 《Clinical Drug Investigation》...